Profile picture

Hadine Joffe, M.D.

Professor of Psychiatry, Beth Israel Deaconess Medical Center
Head of the Department of Psychiatry at Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center
Harvard Title

Paula A. Johnson Professor of Psychiatry in the Field of Women’s Health 

Administrative and Hospital Titles

Chair and Psychiatrist-in Chief of the Department of Psychiatry at Beth Israel Deaconess Medical Center

Other Affiliations

Dana-Farber/Harvard Cancer Center Breast Cancer Program, Psychosocial Oncology and Palliative Care at Dana-Farber Cancer Institute 

Address

Beth Israel Deaconess Medical Center
Department of Psychiatry
330 Brookline Ave
Boston, MA 02215

Publications View
Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors.
Authors: Freeman EW, Ensrud KE, Larson JC, Guthrie KA, Carpenter JS, Joffe H, Newton KM, Sternfeld B, LaCroix AZ.
Psychosom Med
View full abstract on Pubmed
Response to Eskola et al.
Authors: Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL.
Am J Psychiatry
View full abstract on Pubmed
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms.
Authors: Guthrie KA, LaCroix AZ, Ensrud KE, Joffe H, Newton KM, Reed SD, Caan B, Carpenter JS, Cohen LS, Freeman EW, Larson JC, Manson JE, Rexrode K, Skaar TC, Sternfeld B, Anderson GL.
Obstet Gynecol
View full abstract on Pubmed
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial.
Authors: Caan B, LaCroix AZ, Joffe H, Guthrie KA, Larson JC, Carpenter JS, Cohen LS, Freeman EW, Manson JE, Newton K, Reed S, Rexrode K, Shifren J, Sternfeld B, Ensrud K.
Menopause
View full abstract on Pubmed
Duration of menopausal vasomotor symptoms over the menopause transition.
Authors: Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, Hess R, Joffe H, Kravitz HM, Tepper PG, Thurston RC.
JAMA Intern Med
View full abstract on Pubmed
Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Authors: Joffe H, LaCroix AZ, Cohen L.
JAMA Intern Med
View full abstract on Pubmed
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society.
Authors: Manson JE, Ames JM, Shapiro M, Gass ML, Shifren JL, Stuenkel CA, Pinkerton JV, Kaunitz AM, Pace DT, Kagan R, Schnatz PF, Kingsberg SA, Liu JH, Joffe H, Richard-Davis G, Goldstein SR, Schiff I, Utian WH.
Menopause
View full abstract on Pubmed
Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.
Authors: Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Thurston RC, Clark CT, Prairie BA, Moses-Kolko E, Joffe H, Wisner KL.
Am J Psychiatry
View full abstract on Pubmed
Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.
Authors: Ensrud KE, Guthrie KA, Hohensee C, Caan B, Carpenter JS, Freeman EW, LaCroix AZ, Landis CA, Manson J, Newton KM, Otte J, Reed SD, Shifren JL, Sternfeld B, Woods NF, Joffe H.
Sleep
View full abstract on Pubmed
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
Authors: Pinkerton JV, Joffe H, Kazempour K, Mekonnen H, Bhaskar S, Lippman J.
Menopause
View full abstract on Pubmed